ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
- PMID: 23137135
- DOI: 10.1111/1469-0691.12039
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
Abstract
This part of the EFISG guidelines focuses on non-neutropenic adult patients. Only a few of the numerous recommendations can be summarized in the abstract. Prophylactic usage of fluconazole is supported in patients with recent abdominal surgery and recurrent gastrointestinal perforations or anastomotic leakages. Candida isolation from respiratory secretions alone should never prompt treatment. For the targeted initial treatment of candidaemia, echinocandins are strongly recommended while liposomal amphotericin B and voriconazole are supported with moderate, and fluconazole with marginal strength. Treatment duration for candidaemia should be a minimum of 14 days after the end of candidaemia, which can be determined by one blood culture per day until negativity. Switching to oral treatment after 10 days of intravenous therapy has been safe in stable patients with susceptible Candida species. In candidaemia, removal of indwelling catheters is strongly recommended. If catheters cannot be removed, lipid-based amphotericin B or echinocandins should be preferred over azoles. Transoesophageal echocardiography and fundoscopy should be performed to detect organ involvement. Native valve endocarditis requires surgery within a week, while in prosthetic valve endocarditis, earlier surgery may be beneficial. The antifungal regimen of choice is liposomal amphotericin B +/- flucytosine. In ocular candidiasis, liposomal amphotericin B +/- flucytosine is recommended when the susceptibility of the isolate is unknown, and in susceptible isolates, fluconazole and voriconazole are alternatives. Amphotericin B deoxycholate is not recommended for any indication due to severe side effects.
© 2012 The Authors. Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases.
Similar articles
-
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.Lancet. 2005 Oct 22-28;366(9495):1435-42. doi: 10.1016/S0140-6736(05)67490-9. Lancet. 2005. PMID: 16243088 Clinical Trial.
-
Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelines.Infez Med. 2014 Jun;22(2):107-11. Infez Med. 2014. PMID: 24955796 Review.
-
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts.Intensive Care Med. 2013 Dec;39(12):2092-106. doi: 10.1007/s00134-013-3109-3. Epub 2013 Oct 9. Intensive Care Med. 2013. PMID: 24105327
-
Clinical aspects of invasive candidiasis: endocarditis and other localized infections.Drugs. 2009;69 Suppl 1:39-43. doi: 10.2165/11315610-000000000-00000. Drugs. 2009. PMID: 19877733 Review.
-
[INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].Akush Ginekol (Sofiia). 2016;55(4):20-29. Akush Ginekol (Sofiia). 2016. PMID: 29370489 Bulgarian.
Cited by
-
Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the intensive care unit: pooled analyses of the ReSTORE and STRIVE randomised trials.Crit Care. 2024 Oct 28;28(1):348. doi: 10.1186/s13054-024-05117-5. Crit Care. 2024. PMID: 39468640 Free PMC article. Clinical Trial.
-
Occurrence of pathogenic yeast species in artisanal cheeses from Boyacá, Colombia, including fluconazole resistant isolates.F1000Res. 2024 Oct 4;13:789. doi: 10.12688/f1000research.152447.3. eCollection 2024. F1000Res. 2024. PMID: 39464777 Free PMC article.
-
Azole Combinations and Multi-Targeting Drugs That Synergistically Inhibit Candidozyma auris.J Fungi (Basel). 2024 Oct 7;10(10):698. doi: 10.3390/jof10100698. J Fungi (Basel). 2024. PMID: 39452650 Free PMC article. Review.
-
Clinical outcomes of antifungal therapy on Candida pulmonary colonisation in immunocompetent patients with invasive ventilation: a systematic review and meta-analysis.BMJ Open. 2024 Oct 22;14(10):e083918. doi: 10.1136/bmjopen-2024-083918. BMJ Open. 2024. PMID: 39438107 Free PMC article.
-
Strengthening Fungal Infection Diagnosis and Treatment: An In-depth Analysis of Capabilities in Honduras.Open Forum Infect Dis. 2024 Oct 3;11(10):ofae578. doi: 10.1093/ofid/ofae578. eCollection 2024 Oct. Open Forum Infect Dis. 2024. PMID: 39421702 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical